In syngeneic mouse models of gastric cancer, PCSK9 inhibition was demonstrated to upregulate DC infiltration and tumor cell MHC-II expression and subsequently enhance CD8+ T cell activation to realize potent tumor repression. This evidence concerns the gene CD8A and neoplasm.